| Application no. and date | 00982033.3 (espacenet) (Federated) (European Patent Register), 20001129 | | Patent/reg. no. and date | DK/EP 1237559, 20060712 | | Publication date | 20020911 | | Priority no. and date | SE 9904377, 19991201 | | EP pub. no. and date |
EP 1237559 20020911 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | 41053 DK 01 | | Inventor | DIXON, John, AstraZeneca R & D Charnwood
Bakewell Road
Loughborough, Leics. LE11 5RH, GB,
HUMPHRIES, Robert, AstraZeneca R & D Charnwood
Bakewell Road
Loughborough, Leics. LE11 5RH, GB,
JARVIS, Gavin, Uni. of Oxford
Dept. Pharmacology
Mansfield Road
Oxford OX1 3QT, GB,
KIRK, Ian, AstraZeneca R & D Charnwood
Bakewell Road
Bakewell RoaAstraZeneca R & D Charnwood
, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61K 31/7076 (2006.01) , A61P 7/02 (2006.01) | | Title | Farmaceutiske kombinationer som omfatter en P2T-receptor-antagonist og melagatran | | Int. application no. | SE2000002378 | | Int. publication no. | WO2001039781 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
